Assessment of Coronary Pressure Using the Combined Guidewire and Catheter Wirecath
1 other identifier
interventional
45
1 country
1
Brief Summary
In summary, the purpose of the study is to evaluate whether the Wirecath device can be used as a standard pressure wire in a safe and efficient way.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2021
CompletedStudy Start
First participant enrolled
February 25, 2021
CompletedFirst Posted
Study publicly available on registry
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 25, 2021
CompletedJanuary 9, 2024
February 1, 2021
8 months
February 23, 2021
January 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Safety of the Wirecath® will be assessed through the frequency and severity of all adverse events
The safety of the Wirecath@ will be assessed through the frequency and severity of all adverse events reported for study subjects after the completion of the pressure measurement and PCI. The primary endpoint will be achieved when the device has been used on enrolled patients and required measurements have been taken.
30-60 minutes
Secondary Outcomes (2)
Comparison with Abbott pressure wire
30-60 minutes
Comparing pressure-derived coronary flow reserve (CFR) with bolus-thermo CFR, absolute flow CFR and non-invasive doppler derived CFR
14 days
Study Arms (1)
Study arm
OTHERGroup 1 and group 2 will be recruited and assessed in parallel at the discretion of the treating physician, based on the characteristics of the patient. Group 3 will be recruited from suitable patients in group 1 and 2. Simultaneous measurements study (group 1) Regular study group (group 2) Echocardiography-CFR group (group 3)
Interventions
Simultaneous FFR measurements with Wirecath@ and Abbott PressureWire®
Pressure derived CFR with Wirecath®, Thermodilution CFR with Abbott PressureWire®, Absolut flow CFR with Abbott PressureWire® and Hexacath Rayflow catheter®, Non-invasive echo derived CFR
Eligibility Criteria
You may qualify if:
- Adults (\>18yrs age)
- Informed consent given
- Patients with result from diagnostic angiography
- Indication for coronary pressure assessment
You may not qualify if:
- Patients with known Heparin-Induced Thrombocytopenia (HIT) or allergy to heparin.
- Inability to tolerate Adenosine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vastra Gotaland Regionlead
- Cavis Technologies ABcollaborator
Study Sites (1)
Sahlgrenska University Hospital
Gothenburg, 41345, Sweden
Related Publications (1)
Ramunddal T, Dworeck C, Torild P, Andreen S, Gan LM, Hirlekar G, Ioanes D, Myredal A, Odenstedt J, Petursson P, Pylova T, Topel F, Volz S, Hilmersson M, Redfors B, Angeras O. Safety and Feasibility Using a Fluid-Filled Wire to Avoid Hydrostatic Errors in Physiological Intracoronary Measurements. Cardiol Res Pract. 2024 Jan 2;2024:6664482. doi: 10.1155/2024/6664482. eCollection 2024.
PMID: 38204600DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Oskar Angerås, MD PhD
Sahlgrenska University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2021
First Posted
March 1, 2021
Study Start
February 25, 2021
Primary Completion
October 25, 2021
Study Completion
October 25, 2021
Last Updated
January 9, 2024
Record last verified: 2021-02